Patents by Inventor Uwe Kobold

Uwe Kobold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092742
    Abstract: The present invention relates to reagents which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said reagents.
    Type: Application
    Filed: November 2, 2023
    Publication date: March 21, 2024
    Inventors: Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Christoph Seidel, Martin Rempt, Andreas Leinenbach, Giuseppe Prencipe, Silvia Baecher, Simon Ferdinand Loibl, Anna-Skrollan Geiermann, Jelena Milic, Nicole Pirkl
  • Patent number: 11885818
    Abstract: The present invention relates to reagents which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said reagents.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: January 30, 2024
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Christoph Seidel, Martin Rempt, Andreas Leinenbach, Giuseppe Prencipe, Silvia Baecher, Simon Ferdinand Loibl, Anna-Skrollan Geiermann, Jelena Milic, Nicole Pirkl
  • Patent number: 11845733
    Abstract: The present invention relates to reagents which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said reagents.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: December 19, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Christoph Seidel, Martin Rempt, Andreas Leinenbach, Giuseppe Prencipe, Silvia Baecher, Simon Ferdinand Loibl, Anna-Skrollan Geiermann, Jelena Milic, Nicole Pirkl
  • Publication number: 20230333113
    Abstract: The present invention relates to a method, a diagnostic system, a kit and the use thereof for efficiently detection of an analyte of interest by nanoESI mass spectrometry.
    Type: Application
    Filed: April 24, 2023
    Publication date: October 19, 2023
    Inventors: Dieter Heindl, Uwe Kobold, Martin Rempt, Christoph Zuth
  • Publication number: 20230324398
    Abstract: The present invention relates to compounds which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said compounds.
    Type: Application
    Filed: November 21, 2022
    Publication date: October 12, 2023
    Inventors: Dieter Heindl, Uwe Kobold, Hannes Kuchelmeister, Heribert Maerz, Giuseppe Prencipe, Martin Rempt
  • Patent number: 11730821
    Abstract: The present disclosure is directed at an antibody conjugate having an antibody and a tag, wherein one or more element(s) present in the antibody exhibit an isotope ratio which differs from the naturally occurring isotope ratio of the one or more element(s), wherein the amount of the isotope which is less-common in nature, is increased to at least 4% of the atoms of the respective element in the antibody, as well as uses thereof.
    Type: Grant
    Filed: September 21, 2022
    Date of Patent: August 22, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Hartmut Duefel, Uwe Kobold, Andreas Leinenbach
  • Publication number: 20230160904
    Abstract: The present invention relates to compounds which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said compounds.
    Type: Application
    Filed: November 21, 2022
    Publication date: May 25, 2023
    Inventors: Robert Hahn, Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Hannes Kuchelmeister, Simon Loibl, Heribert Maerz, Giuseppe Prencipe, Martin Rempt
  • Publication number: 20230127289
    Abstract: The present invention relates to compounds which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said compounds.
    Type: Application
    Filed: November 20, 2022
    Publication date: April 27, 2023
    Inventors: Robert Hahn, Dieter Heindl, Thomas Hoffmann, Hans-Peter Josel, Uwe Kobold, Hannes Kuchelmeister, Simon Ferdinand Loibl, Daniela Mazzier, Jelena Milic, Giuseppe Prencipe, Martin Rempt, Christoph Seidel
  • Publication number: 20230104200
    Abstract: The present invention relates to compounds which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said compounds.
    Type: Application
    Filed: November 21, 2022
    Publication date: April 6, 2023
    Inventors: Robert Hahn, Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Hannes Kuchelmeister, Daniela Mazzier, Giuseppe Prencipe, Martin Rempt, Christoph Seidel
  • Patent number: 11585811
    Abstract: A method for detecting an analyte involving a) contacting the analyte, a capture agent and a solid surface to form a capture complex attached to a solid surface, b) cleaving at least one covalent bond within the analyte and/or within said capture agent in the capture complex and, thereby, releasing the analyte or a fragment thereof from the capture complex, and c) detecting at least one fragment of the analyte and, thereby, detecting the analyte is disclosed herein. A kit having i) a capture agent binding to an analyte; and ii) an agent cleaving at least one covalent bond within the analyte and/or within the capture agent; and to the use of a protease for releasing fragments of an analyte for detecting the analyte, wherein the analyte is bound to a solid surface via a capture agent is also disclosed herein.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: February 21, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Uwe Kobold, Robert Lang, Andreas Leinenbach
  • Publication number: 20230022977
    Abstract: The present disclosure is directed at an antibody conjugate having an antibody and a tag, wherein one or more element(s) present in the antibody exhibit an isotope ratio which differs from the naturally occurring isotope ratio of the one or more element(s), wherein the amount of the isotope which is less-common in nature, is increased to at least 4% of the atoms of the respective element in the antibody, as well as uses thereof.
    Type: Application
    Filed: September 21, 2022
    Publication date: January 26, 2023
    Inventors: Hartmut Duefel, Uwe Kobold, Andreas Leinenbach
  • Patent number: 11491236
    Abstract: The present disclosure is directed at an antibody conjugate having an antibody and a tag, wherein one or more element(s) present in the antibody exhibit an isotope ratio which differs from the naturally occurring isotope ratio of the one or more element(s), wherein the amount of the isotope which is less-common in nature, is increased to at least 4% of the atoms of the respective element in the antibody, as well as uses thereof.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: November 8, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Harmut Duefel, Uwe Kobold, Andreas Leinenbach
  • Patent number: 11442046
    Abstract: The present invention relates to reagents suitable in the mass spectrometric determination of analyte molecules such as carbohydrates as well as adducts of such reagents and analyte molecules and applications of said reagents and adducts. Further, the present invention relates to methods for the mass spectrometric determination of analyte molecules.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: September 13, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Thomas Carell, Uwe Kobold, Dieter Heindl, Silvia Baecher, Andreas Leinenbach, Martin Rempt, Toni Pfaffeneder, Angie Kirchner, Olesea Kosmatchev, Rene Rahimoff, Sarah Schiffers, Markus Muller
  • Patent number: 11275065
    Abstract: A diagnostic system and method and an interconnected laboratory system comprising clinical diagnostic systems are presented. The diagnostic system comprises a sample preparation module, a liquid chromatography (LC) separation module coupled to the sample preparation module via a sample preparation/LC interface, a mass spectrometer (MS) module coupled to the LC separation module via an LC/MS interface, and a result calculation module for identifying and/or quantifying analytes or substances of interest contained in the samples and passed through the LC separation and MS modules.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: March 15, 2022
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Uwe Kobold, Hubert Paul, Martin Rempt
  • Publication number: 20210333291
    Abstract: The present invention refers to a method for determining intact glycated hemoglobin A (HbA1c) by mass spectrometry (MS), a kit and a diagnostic system adapted for performing the method.
    Type: Application
    Filed: July 8, 2021
    Publication date: October 28, 2021
    Inventors: Uwe KOBOLD, Andreas LEINENBACH, Indranil MITRA, Holger BUSSKAMP
  • Publication number: 20210333290
    Abstract: The present invention refers to a method for determining peptide fragments of glycated hemoglobin A (HbA1c) molecules by mass spectrometry (MS), a reagent kit, and a clinical diagnostic system adapted for performing the method.
    Type: Application
    Filed: July 8, 2021
    Publication date: October 28, 2021
    Inventors: Uwe KOBOLD, Andreas LEINENBACH, Indranil MITRA
  • Patent number: 11099154
    Abstract: A method of quantifying the amount of at least two analytes A1 and A2 involving (a) adding at least one salt (S) to at least a portion (P1) of the sample comprising the at least two analytes A1 and A2, (b) ionizing at least a portion of the sample according to (a) thereby forming an analyte flow comprising the analytes A1 and A2 in ionized form, (c) separating the ionized analytes A1 and A2 from each other by using at least one ion mobility separator (124), wherein the analyte flow according to (b) at least partially passes through the ion mobility separator (124), and (d) quantifying the amount of the separated ionized analytes obtained according to (c), wherein A1 is a pharmaceutically active compound C or derivative thereof and A2 is a metabolite or stereoisomer of C.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: August 24, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Uwe Kobold, Roland Thiele, Noah Weiss, Lauren Brown
  • Publication number: 20210198217
    Abstract: The present invention relates to reagents which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said reagents.
    Type: Application
    Filed: January 21, 2021
    Publication date: July 1, 2021
    Inventors: Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Christoph Seidel, Martin Rempt, Andreas Leinenbach, Giuseppe Prencipe, Silvia Baecher, Simon Ferdinand Loibl, Anna-Skrollan Geiermann, Jelena Milic, Nicole Pirkl
  • Publication number: 20210188788
    Abstract: The present invention relates to reagents which are suitable to be used in mass spectrometry as well as methods of mass spectrometric determination of analyte molecules using said reagents.
    Type: Application
    Filed: January 21, 2021
    Publication date: June 24, 2021
    Inventors: Dieter Heindl, Hans-Peter Josel, Uwe Kobold, Christoph Seidel, Martin Rempt, Andreas Leinenbach, Giuseppe Prencipe, Silvia Baecher, Simon Ferdinand Loibl, Anna-Skrollan Geiermann, Jelena Milic, Robert Hahn, Nicole Pirkl
  • Patent number: 11016098
    Abstract: A method and an apparatus for determining a concentration of a target analyte in a sample of bodily fluid are disclosed. The method involves providing a sample of bodily fluid including the target analyte, providing an internal standard solution including a mixture of components having a plurality of isotopes of the target analyte, wherein a concentration of each isotope is unknown, adding the internal standard solution to the sample, analyzing the sample including the internal standard solution using a mass spectrometer, creating a sample function curve based on signal intensities, wherein the signal intensities define arbitrary units, transferring an analyte signal into a corresponding arbitrary analyte unit by means of the sample function curve, and transferring the arbitrary analyte unit into the concentration of a target analyte by means of a standardization function representing a curve of concentrations depending on the arbitrary units.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: May 25, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Uwe Kobold, Roland Thiele, Noah Weiss, Benjamin Tiemann